Le laboratoire AbbVie met la main sur Pharmacyclics pour 21 milliards de dollars

[ahlam1399]

Le laboratoire AbbVie met la main sur Pharmacyclics pour 21 milliards de dollars
Pharmacyclics développe des médicaments issus des biotech**logies pour le traitement des cancers et des maladies immunitaires.http://rss.lemonde.fr/c/205/f/3050/s/440eed41/sc/14/mf.gif


http://da.feedsportal.com/r/222166857817/u/197/f/3050/c/205/s/440eed41/sc/14/rc/1/rc.img (http://da.feedsportal.com/r/222166857817/u/197/f/3050/c/205/s/440eed41/sc/14/rc/1/rc.htm)
http://da.feedsportal.com/r/222166857817/u/197/f/3050/c/205/s/440eed41/sc/14/rc/2/rc.img (http://da.feedsportal.com/r/222166857817/u/197/f/3050/c/205/s/440eed41/sc/14/rc/2/rc.htm)
http://da.feedsportal.com/r/222166857817/u/197/f/3050/c/205/s/440eed41/sc/14/rc/3/rc.img (http://da.feedsportal.com/r/222166857817/u/197/f/3050/c/205/s/440eed41/sc/14/rc/3/rc.htm)

http://da.feedsportal.com/r/222166857817/u/197/f/3050/c/205/s/440eed41/sc/14/a2.img (http://da.feedsportal.com/r/222166857817/u/197/f/3050/c/205/s/440eed41/sc/14/a2.htm)http://pi.feedsportal.com/r/222166857817/u/197/f/3050/c/205/s/440eed41/sc/14/a2t.img